Retrospective observational study involving pts with aUC who received EV across sixteen hospitals in Spain.
Its findings confirm the efficacy and safety of EV in clinical practice, supporting its use in this patient population.
Although the overall burden of the disease remains considerable, EV demonstrated a substantial effect on disease progression, with satisfactory ORR and TTF.
Authors: Jorge Esteban-Villarrubia, María José Juan Fita, Alfonso Gómez de Liaño, Javier Molina Cerrillo, Patricia Cruz Castellanos, Georgia Angera Palacios, Javier Puente, Oscar Reig Torras, Nil Navarro Gorro, Álvaro Pinto Marín, Saray Galván Ruiz, Diego Cacho Lavín, Iria González Maeso, Núria Sala González, Nuria Lainez Milagro, Urbano Anido, Patricia Carrera Lasfuentes, Daniel Castellano
Year: 2025
Congress: ASCO
